title: Primary renal carcinoid metastatic to the orbit.
abstract: A 70-year-old man with a medical history of metastatic renal carcinoid tumor presented with several months of painless proptosis of the OS. The patient was receiving octreotide and everolimus chemotherapy. MRI revealed a well-circumscribed mass in the left lateral rectus muscle consistent with metastasis. Because the patient was asymptomatic, he was observed and maintained a stable amount of proptosis without diplopia or change in vision.
authors.affiliation: Department of Ophthalmology, SUNY Downstate Medical Center, Brooklyn, New York, U.S.A.
authors.forename: Deep
authors.initials: D
authors.lastname: Parikh
authors.forename: Roman
authors.initials: R
authors.lastname: Shinder
mesh_terms: D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D002276:Carcinoid Tumor / Q000175:diagnosis / Q000556:secondary* / Q000628:therapy; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D000068338:Everolimus; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000473:pathology* / Q000628:therapy; D008279:Magnetic Resonance Imaging; D008297:Male; D009392:Nephrectomy; D015282:Octreotide / Q000627:therapeutic use; D009918:Orbital Neoplasms / Q000175:diagnosis / Q000556:secondary*; D020123:Sirolimus / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D018931:Antineoplastic Agents, Hormonal; D007166:Immunosuppressive Agents; D000068338:Everolimus; D015282:Octreotide; D020123:Sirolimus